DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection

Christine Lücke-huhle, Susanne Hinrichs, Günter Speit

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

During selection for methotrexate resistance, SV40-transformed human skin fibroblasts from patients with ataxia telangiectasia (A-T) underwent amplification of the dihydrofolate reductase (DHFR) gene, experienced nearly complete loss of the integrated SV40 sequences and showed a 3.6-fold increase in Ki-ras gene copy number. Over a period of months methotrexate-resistant (MTXr) A-T subclones were obtained, which were able to grow in progressively increasing MTX concentrations up to 100 μM. The ED50 values determined as the effective dose of MTX causing 50% growth inhibition in comparison to control cells increased from 3×10-2 μM for MTXs AT5BI-VA cells to 250 μM MTX for the MTXr AX100 subclone. In contrast, human skin fibroblasts of healthy individuals did not show DHFR gene amplification and loss of SV40 sequences under comparable conditions and were unable to grow in MTX concentrations >1 μM. Gene amplification and loss of DNA sequences are features underlying the genomic instability known to be a characteristic property of A-T cells and being probably responsible for the high cancer incidence in these patients.

Original languageEnglish (US)
Pages (from-to)1801-1806
Number of pages6
JournalCarcinogenesis
Volume8
Issue number12
DOIs
StatePublished - Dec 1987

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection'. Together they form a unique fingerprint.

  • Cite this